During the past decade, Bausch & Lomb, Incorporated conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 26 clinical trials were completed, i.e. on average, 1300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 17 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bausch & Lomb, Incorporated" #1 collaborator was "Bausch Health Americas, Inc." with 1 trials as a collaborator, "ORA, Inc." with 1 trials as a collaborator and "Synteract, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Bausch & Lomb, Incorporated" are "Myopia" (10 trials), "Cataract" (6 trials), "Inflammation" (4 trials), "Bacterial Conjunctivitis" (3 trials) and "Presbyopia" (3 trials). Many other conditions were trialed in "Bausch & Lomb, Incorporated" in a lesser frequency.

Most popular intervention types in "Bausch & Lomb, Incorporated" are "Drug" (18 trials), "Device" (17 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mapracorat" (5 trials), "Vehicle" (5 trials), "BOL-303259-X" (3 trials), "Besifloxacin" (3 trials) and "Air Optix Aqua" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bausch & Lomb, Incorporated" are 34 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Bausch & Lomb, Incorporated". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Bausch & Lomb, Incorporated, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Bausch & Lomb, Incorporated, 4 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 15 trials that are defined as “Not Applicable".